Literature DB >> 16018149

Progress in clinical neurosciences: cognitive markers of progression in Alzheimer's disease.

Pearl Behl1, Taresa L Stefurak, Sandra E Black.   

Abstract

The objective of this review is to summarize the literature on Alzheimer's disease progression utilizing cognitive batteries to track change over time. Studies published in English and obtained through PubMed searches (1983-2004) were included (i) if they had a longitudinal design and followed probable Alzheimer's patients diagnosed by National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association or Diagnostic and Statistical Manual III/IV criteria, and (ii) if the techniques used for serial assessment were well-established in terms of validity and reliability. Longitudinal studies examining Alzheimer's disease progression report highly variable annual rates of change in decline rate. It remains unclear if this reflects disease subgroups or stage-related rate of decline. In conclusion a combination of stage-appropriate cognitive tests such as the Mattis Dementia Rating Scale and the Severe Impairment Battery, along with appropriate statistical methods to account for individual variability in decline rates, can capture the progression of Alzheimer disease and may be useful in further investigation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16018149     DOI: 10.1017/s0317167100003917

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  19 in total

Review 1.  Alzheimer's disease: the strength of association of costs with different measures of disease severity.

Authors:  J Mauskopf; J Racketa; E Sherrill
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

2.  Caregiver personality predicts rate of cognitive decline in a community sample of persons with Alzheimer's disease. The Cache County Dementia Progression Study.

Authors:  Maria C Norton; Christine Clark; Elizabeth B Fauth; Kathleen W Piercy; Roxane Pfister; Robert C Green; Christopher D Corcoran; Peter V Rabins; Constantine G Lyketsos; Joann T Tschanz
Journal:  Int Psychogeriatr       Date:  2013-07-05       Impact factor: 3.878

3.  Caregiver-recipient closeness and symptom progression in Alzheimer disease. The Cache County Dementia Progression Study.

Authors:  Maria C Norton; Kathleen W Piercy; Peter V Rabins; Robert C Green; John C S Breitner; Truls Ostbye; Christopher Corcoran; Kathleen A Welsh-Bohmer; Constantine G Lyketsos; Joann T Tschanz
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-06-29       Impact factor: 4.077

4.  Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study.

Authors:  JoAnn T Tschanz; Chris D Corcoran; Sarah Schwartz; Katherine Treiber; Robert C Green; Maria C Norton; Michelle M Mielke; Kathleen Piercy; Martin Steinberg; Peter V Rabins; Jeanne-Marie Leoutsakos; Kathleen A Welsh-Bohmer; John C S Breitner; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2011-06       Impact factor: 4.105

5.  Caregiver coping strategies predict cognitive and functional decline in dementia: the Cache County Dementia Progression Study.

Authors:  JoAnn T Tschanz; Kathleen Piercy; Chris D Corcoran; Elizabeth Fauth; Maria C Norton; Peter V Rabins; Brian T Tschanz; M Scott Deberard; Christine Snyder; Courtney Smith; Lester Lee; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-02       Impact factor: 4.105

6.  Relation of brain natriuretic peptide levels to cognitive dysfunction in adults > 55 years of age with cardiovascular disease.

Authors:  John Gunstad; Athena Poppas; Steven Smeal; Robert H Paul; David F Tate; Angela L Jefferson; Daniel E Forman; Ronald A Cohen
Journal:  Am J Cardiol       Date:  2006-06-28       Impact factor: 2.778

7.  The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onset.

Authors:  Joann T Tschanz; Maria C Norton; Peter P Zandi; Constantine G Lyketsos
Journal:  Int Rev Psychiatry       Date:  2013-12

8.  Both Financial and Cognitive Decline Predict Clinical Progression in MCI.

Authors:  Adam Gerstenecker; Kristen L Triebel; Roy Martin; Scott Snyder; Daniel C Marson
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Jan-Mar       Impact factor: 2.703

9.  SPIRIT advance care planning intervention in early stage dementias: An NIH stage I behavioral intervention development trial.

Authors:  Mi-Kyung Song; Sandra E Ward; Kenneth Hepburn; Sudeshna Paul; Raj C Shah; Darby J Morhardt
Journal:  Contemp Clin Trials       Date:  2018-06-02       Impact factor: 2.226

10.  Alzheimer's Disease, Diagnosis and the Need for Biomarkers.

Authors:  Claudie Hooper; Simon Lovestone; Ricardo Sainz-Fuertes
Journal:  Biomark Insights       Date:  2008-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.